We are live on ! Find out more
WC

Wexford Capital Portfolio holdings

AUM $690M
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+6.82%
1 Year Est. Return
+57.92%
3 Year Est. Return
+92.61%
5 Year Est. Return
10 Year Est. Return
AUM
$466M
AUM Growth
+$14.4M
Cap. Flow
-$1.46M
Cap. Flow %
-0.31%
Top 10 Hldgs %
40.91%
Holding
301
New
120
Increased
34
Reduced
46
Closed
87

Sector Composition

Rank Sector Weight
1 Industrials 23.82%
2 Energy 18.87%
3 Utilities 8.4%
4 Healthcare 7.39%
5 Consumer Staples 4.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LUMN icon
176
Lumen
LUMN
$6.91B
$24.5K 0.01%
+13,380
New +$19K
FSR
177
DELISTED
Fisker Inc.
FSR
$24.5K 0.01%
+13,990
New +$49.5K
TWOU
178
DELISTED
2U Inc
TWOU
$24.4K 0.01%
+660
New +$32.2K
FOSL icon
179
Fossil Group
FOSL
$360M
$24K 0.01%
+16,460
New +$24.2K
SST icon
180
System1
SST
$16.5M
$23.9K 0.01%
+1,075
New +$15.9K
NVTA
181
DELISTED
Invitae Corporation
NVTA
$23.7K 0.01%
+37,880
New +$22.7K
KPTI icon
182
Karyopharm Therapeutics
KPTI
$44.4M
$23.6K 0.01%
+1,819
New +$24.5K
SEER icon
183
Seer Inc
SEER
$122M
$23K ﹤0.01%
+11,870
New +$21.1K
VOR icon
184
Vor Biopharma
VOR
$1.21B
$22.6K ﹤0.01%
+503
New +$20.8K
PROK icon
185
ProKidney
PROK
$334M
$22.4K ﹤0.01%
+12,580
New +$27K
KZR
186
DELISTED
Kezar Life Sciences
KZR
$22.1K ﹤0.01%
+2,332
New +$20.5K
OCEA
187
DELISTED
Ocean Biomedical, Inc. Common Stock
OCEA
$22K ﹤0.01%
+33,310
New +$45.7K
ERAS icon
188
Erasca
ERAS
$6.38B
$21.9K ﹤0.01%
+10,290
New +$21.7K
AEVA
189
Aeva Technologies
AEVA
$1.4B
$21.6K ﹤0.01%
+5,706
New +$18.2K
ME
190
DELISTED
23andMe Holding Co
ME
$21.3K ﹤0.01%
+1,169
New +$20.2K
NUVB icon
191
Nuvation Bio
NUVB
$2.24B
$21.1K ﹤0.01%
13,997
-25,105
-64% -$32.3K
ACRS icon
192
Aclaris Therapeutics
ACRS
$835M
$21K ﹤0.01%
+20,000
New +$61K
ORGN
193
DELISTED
Origin Materials
ORGN
$21K ﹤0.01%
+837
New +$24K
NOTE
194
DELISTED
FiscalNote
NOTE
$20.8K ﹤0.01%
+1,522
New +$25.1K
ASRT
195
DELISTED
Assertio
ASRT
$20.6K ﹤0.01%
+1,282
New +$31.7K
AGEN
196
Agenus
AGEN
$346M
$20.6K ﹤0.01%
+1,242
New +$20.6K
PRPL icon
197
Purple Innovation
PRPL
$42.4M
$19.9K ﹤0.01%
+773
New +$19.8K
FEAM icon
198
5E Advanced Materials
FEAM
$54.8M
$19.9K ﹤0.01%
+612
New +$29.8K
CMPX icon
199
Compass Therapeutics
CMPX
$357M
$19.8K ﹤0.01%
+12,700
New +$22K
WKHS icon
200
Workhorse Group
WKHS
$37.1M
$19.4K ﹤0.01%
+18
New +$21.5K

Similar funds

Wexford Capital's Q4 2023 Portfolio in Review

As of Q4 2023, Wexford Capital held 301 positions worth $466M, up 3.2% from $452M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Wexford Capital's Q4 2023 filing shows 120 new, 34 increased, 46 reduced and 87 closed positions. Its largest new stake was iShares MSCI Canada ETF: 271,555 shares worth $9.96M. The largest sale was Canadian Natural Resources, an estimated $15.3M.

By sector, the portfolio is most concentrated in Industrials at 24% of assets, down from 26% a quarter earlier, followed by Energy and Utilities.

  • Wexford Capital's largest Q4 2023 buy was iShares MSCI Canada ETF: 271,555 shares worth $9.96M.
  • Wexford Capital added most to International Seaways in Q4 2023, an estimated $7.06M increase.
  • Wexford Capital's biggest Q4 2023 reduction was Canadian Natural Resources, cutting an estimated $15.3M.
  • Wexford Capital fully exited Rogers Communications in Q4 2023, selling an estimated $9.9M.
  • Wexford Capital's ten largest holdings make up 41% of its $466M portfolio in Q4 2023.
  • Wexford Capital opened 120 new positions and closed 87 in Q4 2023.
  • Wexford Capital's portfolio value rose 3.2% quarter-over-quarter to $466M.

Based on Wexford Capital's 13F filing for Q4 2023, filed 15 Feb 2024.